• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • William D. Travis, Elisabeth Brambilla, +45 authors David Yankelewitz
  • Medicine
  • Journal of thoracic oncology : official…
  • 2011 (First Publication: 1 February 2011)
  • Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To address advances in oncology, molecular biology, pathology, radiology, and surgery of lung adenocarcinoma, anExpand
  • Frank V. Fossella, R F Devore, +14 authors Luz Hammershaimb
  • Medicine
  • 2000 (First Publication: 12 June 2000)
  • PURPOSE: To confirm the promising phase II results of docetaxel monotherapy, this phase III trial was conducted of chemotherapy for patients with advanced non–small-cell lung cancer (NSCLC) who hadExpand
  • Walter J. Curran, Rebecca Paulus, +10 authors James D. Cox
  • Medicine
  • Journal of the National Cancer Institute
  • 2011 (First Publication: 5 October 2011)
  • BACKGROUND The combination of chemotherapy with thoracic radiotherapy (TRT) compared with TRT alone has been shown to confer a survival advantage for good performance status patients with stage IIIExpand
  • Ji-Youn Han, Hyeong-Seok Lim, +6 authors Jin Soo Lee
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2006 (First Publication: 20 May 2006)
  • PURPOSE To determine whether uridine diphosphate-glucuronosyltransferase 1A1, UGT1A7, and UGT1A9 polymorphisms affect the pharmacokinetics (PK) of irinotecan and treatment outcome of Korean patientsExpand
  • Tony Mok, Yi-long Wu, +14 authors Jin Soo Lee
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2009 (First Publication: 20 October 2009)
  • PURPOSE This study investigated whether sequential administration of erlotinib and chemotherapy improves clinical outcomes versus chemotherapy alone in unselected, chemotherapy-naïve patients withExpand
  • Tony Shu Kam Mok, Yi-Long Wu, +17 authors Lin Wu
  • Medicine
  • Clinical Cancer Research
  • 2015 (First Publication: 31 March 2015)
  • Purpose: Blood-based circulating-free (cf) tumor DNA may be an alternative to tissue-based EGFR mutation testing in NSCLC. This exploratory analysis compares matched tumor and blood samples from theExpand